Treatment of drug-resistant cancer with 2-aryl-2-(3-indolyl) acetohydroxamates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9206124
APP PUB NO 20150105439A1
SERIAL NO

14516543

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A pharmaceutical composition, a method of producing same, and a method of providing cancer therapy therein comprising a pharmaceutically acceptable excipient or carrier and a compound Formula 3 as follows:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION801 LEROY PLACE SOCORRO NM 87801

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Akensov, Alexander V Stavropol, RU 1 1
Avilucea, Gabriel Socorro, US 2 1
Frolova, Liliya Socorro, US 8 3
Kornienko, Alexander San Marcos, US 9 14
Rogelj, Snezna Socorro, US 20 39

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00